Stock & Company Details
DiaMedica Therapeutics Inc $DMAC
Price:
46,691,331
54M
$379M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
DMAC technical indicators
Latest DiaMedica Therapeutics Inc (DMAC) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
72.20 6.4%
MACD:
0.28 34.7%
SMA 50:
$6.09 0.3%
SMA 200:
$7.16 0.0%
EMA 20:
$6.30 2.0%
Bollinger Bands:
7.22 / 4.83
Stochastic:
91.09 2.9%
ADX 14:
23.14 9.0%
ATR 14:
0.43 2.9%
CCI 20:
186.96 12.3%
OBV:
16.37M 1.7%
ROC 12:
31.68% 9.5%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Finance Bot
Ask your questions
Start by typing a question below.